Article Text

Download PDFPDF

Correction: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
Free

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Smolen JS, Landewé RBM, Bergstra SA, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis 2023;82:3–18.

The competing interests statement was erroneously omitted and is now included in the online version. This correction has not been made in print.

Linked Articles

  • Recommendation
    Josef S Smolen Robert B M Landewé Sytske Anne Bergstra Andreas Kerschbaumer Alexandre Sepriano Daniel Aletaha Roberto Caporali Christopher John Edwards Kimme L Hyrich Janet E Pope Savia de Souza Tanja A Stamm Tsutomu Takeuchi Patrick Verschueren Kevin L Winthrop Alejandro Balsa Joan M Bathon Maya H Buch Gerd R Burmester Frank Buttgereit Mario Humberto Cardiel Katerina Chatzidionysiou Catalin Codreanu Maurizio Cutolo Alfons A den Broeder Khadija El Aoufy Axel Finckh João Eurico Fonseca Jacques-Eric Gottenberg Espen A Haavardsholm Annamaria Iagnocco Kim Lauper Zhanguo Li Iain B McInnes Eduardo F Mysler Peter Nash Gyula Poor Gorica G Ristic Felice Rivellese Andrea Rubbert-Roth Hendrik Schulze-Koops Nikolay Stoilov Anja Strangfeld Annette van der Helm-van Mil Elsa van Duuren Theodora P M Vliet Vlieland René Westhovens Désirée van der Heijde